Daily FNArena News - Australia
All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure ChestLatest Stories
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
4:46 PM
The Chartist sees a healthy pause in Aristocrat Leisure shares, following the breakout, setting the stage for another leg higher
Jul 30 2026
Despite growing investor scepticism, analysts believe the next phase of the AI investment cycle will be driven by productivity gains, data centre expansion and a widening group of ASX-listed beneficiaries
Jul 30 2026
A stronger-than-expected first-quarter update has prompted brokers to lift earnings forecasts and price targets for James Hardie Industries
Jul 28 2026
Previous Stories
The Market In Numbers – 25 Jul 2026
Jul 25 2026
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
Strong Result, Can Telix Continue To Deliver?
Jul 22 2026
Telix has continued to outperform operationally in 2026, but future upside is increasingly dependent on pipeline execution, regulatory approvals and therapeutic progress.
AI’s Show Me The Money Moment
Jul 22 2026
AI monetisation is becoming measurable as Australian banks, businesses and data centre investment accelerate adoption, supporting productivity gains while reshaping the economy and labour market
The Market In Numbers – 18 Jul 2026
Jul 18 2026
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
Supermarkets Behemoths Remain In Focus
Jul 15 2026
Supplier surveys and consumer spending data have analysts divided over supermarket valuations and where the best value lays across the consumer sector
Are Headwinds Building For ResMed In FY27?
Jul 14 2026
While one broker has turned more cautious on ResMed due to a one-off cost and risk of rising competition, analysts broadly welcome the MatrixCare sale as a strategic refocus backed by a sizeable shareholder return
The Market In Numbers – 11 Jul 2026
Jul 11 2026
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
FY26 In Review: Up Thanks To Miners & Dividends
Jul 07 2026
The Resources sector powered the ASX200 higher in FY26, but June featured falling commodity prices and investors rotating into the laggards
Pexa To Contest Major Revenue Hit In Australia
Jul 06 2026
The regulator has proposed a significant cut to digital conveyancer Pexa Group’s service fees but the company intends to fight back
The Market In Numbers – 4 Jul 2026
Jul 04 2026
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
